Grants and Giving Scientific Focus
Apellis currently accepts requests for grants and giving support pertaining to the following therapeutic areas and patient communities:
- Paroxysmal Nocturnal Hemoglobinuria (PNH)
- Geographic Atrophy (GA)/Dry Macular Degeneration (AMD)
- Amyotrophic lateral sclerosis (ALS)
- Immune complex membranoproliferative glomerulonephritis (IC-MPGN) and C3 glomerulopathy (C3G)
- Cold Agglutinin Disease (CAD)
- Hematopoietic stem cell transplantation-associated thrombotic microangiopathy (HSCT-TMA)
- Patient organizations working in areas that overlap with our medicines and pipeline
- Other investigational science observed within Apellis’ pipeline (particularly for non-CME grants)
This list is evaluated and updated regularly. Apellis reserves the right to review or modify therapeutic areas of interest at any time without notice.